Published in J Biol Chem on February 02, 2012
Crystal structure of a human GABAA receptor. Nature (2014) 2.22
Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population. PLoS One (2016) 1.40
Ionotropic GABA and Glutamate Receptor Mutations and Human Neurologic Diseases. Mol Pharmacol (2015) 1.16
The role of protein N-glycosylation in neural transmission. Glycobiology (2014) 0.95
N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. Neuropsychopharmacology (2013) 0.91
The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type. Front Neural Circuits (2014) 0.90
Three epilepsy-associated GABRG2 missense mutations at the γ+/β- interface disrupt GABAA receptor assembly and trafficking by similar mechanisms but to different extents. Neurobiol Dis (2014) 0.86
Genetic neurological channelopathies: molecular genetics and clinical phenotypes. J Neurol Neurosurg Psychiatry (2015) 0.85
Epileptic encephalopathy de novo GABRB mutations impair GABAA receptor function. Ann Neurol (2016) 0.84
N-glycosylation in regulation of the nervous system. Adv Neurobiol (2014) 0.83
Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits. Neurochem Res (2013) 0.83
Dodecyl maltopyranoside enabled purification of active human GABA type A receptors for deep and direct proteomic sequencing. Mol Cell Proteomics (2014) 0.78
Large Scale Gene Expression Meta-Analysis Reveals Tissue-Specific, Sex-Biased Gene Expression in Humans. Front Genet (2016) 0.77
Association analysis of GABRB3 promoter variants with heroin dependence. PLoS One (2014) 0.76
Single-cell genetic expression of mutant GABAA receptors causing Human genetic epilepsy alters dendritic spine and GABAergic bouton formation in a mutation-specific manner. Front Cell Neurosci (2014) 0.76
Altered Channel Conductance States and Gating of GABAA Receptors by a Pore Mutation Linked to Dravet Syndrome. eNeuro (2017) 0.75
Genome-wide Membrane Protein Structure Prediction. Curr Genomics (2013) 0.75
Introduced Amino Terminal Epitopes Can Reduce Surface Expression of Neuronal Nicotinic Receptors. PLoS One (2016) 0.75
Differential Alteration in Expression of Striatal GABAAR Subunits in Mouse Models of Huntington's Disease. Front Mol Neurosci (2017) 0.75
SWISS-MODEL: An automated protein homology-modeling server. Nucleic Acids Res (2003) 25.86
Refined structure of the nicotinic acetylcholine receptor at 4A resolution. J Mol Biol (2005) 12.16
Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors. Nature (2001) 11.78
Roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem (2004) 8.80
X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature (2008) 6.02
X-ray structure of a pentameric ligand-gated ion channel in an apparently open conformation. Nature (2008) 5.77
International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev (2008) 4.49
The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci (1992) 4.45
Subunit composition, distribution and function of GABA(A) receptor subtypes. Curr Top Med Chem (2002) 4.45
Crystal structure of the extracellular domain of nAChR alpha1 bound to alpha-bungarotoxin at 1.94 A resolution. Nat Neurosci (2007) 4.28
Structural requirements of N-glycosylation of proteins. Studies with proline peptides as conformational probes. Biochem J (1983) 4.15
Do salt bridges stabilize proteins? A continuum electrostatic analysis. Protein Sci (1994) 3.92
Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann Neurol (2003) 2.79
Forced subunit assembly in alpha1beta2gamma2 GABAA receptors. Insight into the absolute arrangement. J Biol Chem (2002) 2.44
Enhanced tonic GABAA inhibition in typical absence epilepsy. Nat Med (2009) 2.38
Stoichiometry and assembly of a recombinant GABAA receptor subtype. J Neurosci (1997) 2.35
Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci (2002) 2.32
N-glycan structure dictates extension of protein folding or onset of disposal. Nat Chem Biol (2007) 2.06
Subunit arrangement of gamma-aminobutyric acid type A receptors. J Biol Chem (2001) 1.97
Congenital disorders of glycosylation. Ann N Y Acad Sci (2010) 1.93
A splice-site mutation in GABRG2 associated with childhood absence epilepsy and febrile convulsions. Arch Neurol (2002) 1.77
Evolving concepts on the pathophysiology of absence seizures: the cortical focus theory. Arch Neurol (2005) 1.72
Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet (2008) 1.64
Intraburst kinetic properties of the GABAA receptor main conductance state of mouse spinal cord neurones in culture. J Physiol (1990) 1.56
N-glycans are direct determinants of CFTR folding and stability in secretory and endocytic membrane traffic. J Cell Biol (2009) 1.54
Single channel properties of recombinant GABAA receptors containing gamma 2 or delta subtypes expressed with alpha 1 and beta 3 subtypes in mouse L929 cells. J Physiol (1997) 1.46
Oligosaccharyl transferase: the central enzyme in the pathway of glycoprotein assembly. Biochim Biophys Acta (1987) 1.43
The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J Neurosci (2009) 1.30
Identification of amino acid residues within GABA(A) receptor beta subunits that mediate both homomeric and heteromeric receptor expression. J Neurosci (1999) 1.19
The epilepsy mutation, gamma2(R43Q) disrupts a highly conserved inter-subunit contact site, perturbing the biogenesis of GABAA receptors. Mol Cell Neurosci (2005) 1.12
Differences between Asn-Xaa-Thr-containing peptides: a comparison of solution conformation and substrate behavior with oligosaccharyltransferase. Biochemistry (1991) 1.05
GABA(A) receptor assembly. Identification and structure of gamma(2) sequences forming the intersubunit contacts with alpha(1) and beta(3) subunits. J Biol Chem (2000) 1.05
Structural elements involved in activation of the gamma-aminobutyric acid type A (GABAA) receptor. Biochem Soc Trans (2004) 1.03
A gamma 2(R43Q) mutation, linked to epilepsy in humans, alters GABAA receptor assembly and modifies subunit composition on the cell surface. J Biol Chem (2006) 1.02
Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating. J Biol Chem (2010) 1.02
The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression. J Physiol (2011) 0.96
N-linked oligosaccharides direct the differential assembly and secretion of inhibin alpha- and betaA-subunit dimers. Mol Endocrinol (2007) 0.94
Structure and function of AChBP, homologue of the ligand-binding domain of the nicotinic acetylcholine receptor. Ann N Y Acad Sci (2003) 0.94
Developmental co-regulation of the beta and gamma GABAA receptor subunits with distinct alpha subunits in the human dorsolateral prefrontal cortex. Int J Dev Neurosci (2010) 0.93
Role of the N-terminal alpha-helix in biogenesis of alpha7 nicotinic receptors. J Neurochem (2008) 0.92
Site-directed mutagenesis of N-linked glycosylation sites on the gamma-aminobutyric acid type A receptor alpha 1 subunit. Mol Pharmacol (1994) 0.90
N-glycosylation efficiency is determined by the distance to the C-terminus and the amino acid preceding an Asn-Ser-Thr sequon. Protein Sci (2011) 0.90
Linkage and mutational analysis of CLCN2 in childhood absence epilepsy. Epilepsy Res (2007) 0.86
Linkage and association analysis of CACNG3 in childhood absence epilepsy. Eur J Hum Genet (2007) 0.86
Common polymorphisms in the CACNA1H gene associated with childhood absence epilepsy in Chinese Han population. Ann Hum Genet (2006) 0.83
Effects of Kv1.1 channel glycosylation on C-type inactivation and simulated action potentials. Brain Res (2005) 0.83
Definitive evidence that a single N-glycan among three glycans on inducible costimulator is required for proper protein trafficking and ligand binding. Biochem Biophys Res Commun (2009) 0.77
[T-type calcium channel gene-CACNA1H is a susceptibility gene to childhood absence epilepsy]. Zhonghua Er Ke Za Zhi (2005) 0.77
Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit. J Neurosci (2002) 2.49
Extrasynaptic GABAA receptors: form, pharmacology, and function. J Neurosci (2009) 2.39
Neurosteroids shift partial agonist activation of GABA(A) receptor channels from low- to high-efficacy gating patterns. J Neurosci (2003) 1.66
GABRD encoding a protein for extra- or peri-synaptic GABAA receptors is a susceptibility locus for generalized epilepsies. Hum Mol Genet (2004) 1.65
Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet (2008) 1.64
Alternatively spliced isoforms of TRIP8b differentially control h channel trafficking and function. J Neurosci (2009) 1.63
Reduced sodium channel density, altered voltage dependence of inactivation, and increased susceptibility to seizures in mice lacking sodium channel beta 2-subunits. Proc Natl Acad Sci U S A (2002) 1.52
The GABAA receptor gamma2 subunit R43Q mutation linked to childhood absence epilepsy and febrile seizures causes retention of alpha1beta2gamma2S receptors in the endoplasmic reticulum. J Neurosci (2004) 1.48
Why does fever trigger febrile seizures? GABAA receptor gamma2 subunit mutations associated with idiopathic generalized epilepsies have temperature-dependent trafficking deficiencies. J Neurosci (2006) 1.45
The GABAA receptor alpha1 subunit epilepsy mutation A322D inhibits transmembrane helix formation and causes proteasomal degradation. Proc Natl Acad Sci U S A (2007) 1.38
Two different mechanisms of disinhibition produced by GABAA receptor mutations linked to epilepsy in humans. J Neurosci (2002) 1.34
Endoplasmic reticulum retention and associated degradation of a GABAA receptor epilepsy mutation that inserts an aspartate in the M3 transmembrane segment of the alpha1 subunit. J Biol Chem (2005) 1.33
Enhanced macroscopic desensitization shapes the response of alpha4 subtype-containing GABAA receptors to synaptic and extrasynaptic GABA. J Physiol (2006) 1.32
The GABRG2 mutation, Q351X, associated with generalized epilepsy with febrile seizures plus, has both loss of function and dominant-negative suppression. J Neurosci (2009) 1.30
Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci (2008) 1.30
Oxidative modification of M-type K(+) channels as a mechanism of cytoprotective neuronal silencing. EMBO J (2006) 1.28
Slow phases of GABA(A) receptor desensitization: structural determinants and possible relevance for synaptic function. J Physiol (2002) 1.27
Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res (2002) 1.27
Pentobarbital differentially modulates alpha1beta3delta and alpha1beta3gamma2L GABAA receptor currents. Mol Pharmacol (2004) 1.18
Homomeric and heteromeric assembly of KCNQ (Kv7) K+ channels assayed by total internal reflection fluorescence/fluorescence resonance energy transfer and patch clamp analysis. J Biol Chem (2008) 1.16
Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X. J Neurosci (2009) 1.15
Delta subunit susceptibility variants E177A and R220H associated with complex epilepsy alter channel gating and surface expression of alpha4beta2delta GABAA receptors. J Neurosci (2006) 1.14
Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies. Trends Mol Med (2009) 1.13
Multiple actions of propofol on alphabetagamma and alphabetadelta GABAA receptors. Mol Pharmacol (2004) 1.12
Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J Neurochem (2004) 1.10
Ca2+/calmodulin disrupts AKAP79/150 interactions with KCNQ (M-Type) K+ channels. J Neurosci (2010) 1.09
A conserved Cys-loop receptor aspartate residue in the M3-M4 cytoplasmic loop is required for GABAA receptor assembly. J Biol Chem (2008) 1.09
NIK is involved in nucleosomal regulation by enhancing histone H3 phosphorylation by IKKalpha. J Biol Chem (2006) 1.08
Beta subunit phosphorylation selectively increases fast desensitization and prolongs deactivation of alpha1beta1gamma2L and alpha1beta3gamma2L GABA(A) receptor currents. J Neurosci (2003) 1.07
The mouse Chrna4 A529T polymorphism alters the ratio of high to low affinity alpha 4 beta 2 nAChRs. Neuropharmacology (2003) 1.06
Microscopic kinetic determinants of macroscopic currents: insights from coupling and uncoupling of GABAA receptor desensitization and deactivation. J Physiol (2007) 1.04
Glycosylation of {beta}2 subunits regulates GABAA receptor biogenesis and channel gating. J Biol Chem (2010) 1.02
Determinants within the turret and pore-loop domains of KCNQ3 K+ channels governing functional activity. Biophys J (2008) 1.02
Functional characterization of the new human GABA(A) receptor mutation beta3(R192H). Hum Genet (2002) 1.00
Hereditary spastic paraplegia-associated mutations in the NIPA1 gene and its Caenorhabditis elegans homolog trigger neural degeneration in vitro and in vivo through a gain-of-function mechanism. J Neurosci (2008) 1.00
GABA(A) receptor alpha1 subunit mutation A322D associated with autosomal dominant juvenile myoclonic epilepsy reduces the expression and alters the composition of wild type GABA(A) receptors. J Biol Chem (2010) 1.00
Slow degradation and aggregation in vitro of mutant GABAA receptor gamma2(Q351X) subunits associated with epilepsy. J Neurosci (2010) 0.99
GABA(A) receptor function and pharmacology in epilepsy and status epilepticus. Curr Opin Pharmacol (2003) 0.97
Modulation of spontaneous and GABA-evoked tonic alpha4beta3delta and alpha4beta3gamma2L GABAA receptor currents by protein kinase A. J Neurophysiol (2009) 0.96
γ-Aminobutyric acid type A (GABAA) receptor α subunits play a direct role in synaptic versus extrasynaptic targeting. J Biol Chem (2012) 0.96
The GABRA6 mutation, R46W, associated with childhood absence epilepsy, alters 6β22 and 6β2 GABA(A) receptor channel gating and expression. J Physiol (2011) 0.96
Structural determinants of benzodiazepine allosteric regulation of GABA(A) receptor currents. J Neurosci (2005) 0.95
Modifications of a commercial perfusion system for use in ultrafast solution exchange during patch clamp recording. Biotechniques (2003) 0.95
Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype. Ann Neurol (2013) 0.95
Gating consequences of charge neutralization of arginine residues in the S4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit. Biophys J (2008) 0.94
Mutation of the GABAA receptor M1 transmembrane proline increases GABA affinity and reduces barbiturate enhancement. Neuropharmacology (2002) 0.94
Alteration of GABAergic neurotransmission by pulsed infrared laser stimulation. J Neurosci Methods (2010) 0.93
Proton modulation of alpha 1 beta 3 delta GABAA receptor channel gating and desensitization. J Neurophysiol (2004) 0.89
Barbiturates require the N terminus and first transmembrane domain of the delta subunit for enhancement of alpha1beta3delta GABAA receptor currents. J Biol Chem (2010) 0.89
Lipopolysaccharide-dependent interaction between PU.1 and c-Jun determines production of lipocalin-type prostaglandin D synthase and prostaglandin D2 in macrophages. Am J Physiol Lung Cell Mol Physiol (2009) 0.88
An N-terminal histidine is the primary determinant of alpha subunit-dependent Cu2+ sensitivity of alphabeta3gamma2L GABA(A) receptors. Mol Pharmacol (2003) 0.87
Alterations of GABA A-receptor function and allosteric modulation during development of status epilepticus. J Neurophysiol (2008) 0.86
The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1. Mol Cell Neurosci (2010) 0.86
The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through. Neurobiol Dis (2012) 0.85
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S4 region of KCNQ2 causing benign familial neonatal convulsions. J Neurosci (2007) 0.85
The intronic GABRG2 mutation, IVS6+2T->G, associated with childhood absence epilepsy altered subunit mRNA intron splicing, activated nonsense-mediated decay, and produced a stable truncated γ2 subunit. J Neurosci (2012) 0.85
Expression and function of inwardly rectifying potassium channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab (2006) 0.84
Context-dependent modulation of alphabetagamma and alphabetadelta GABA A receptors by penicillin: implications for phasic and tonic inhibition. Neuropharmacology (2008) 0.84
Impaired surface αβγ GABA(A) receptor expression in familial epilepsy due to a GABRG2 frameshift mutation. Neurobiol Dis (2012) 0.84
Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits. Neurochem Res (2013) 0.83
Benzodiazepine modulation of GABA(A) receptor opening frequency depends on activation context: a patch clamp and simulation study. Epilepsy Res (2009) 0.82
Pore determinants of KCNQ3 K+ current expression. Biophys J (2012) 0.80
Mechanisms of action of antiseizure drugs. Handb Clin Neurol (2012) 0.79
Potent growth-inhibitory effect of a dual cancer-specific oncolytic adenovirus expressing apoptin on prostate carcinoma. Int J Oncol (2013) 0.78
Impact of technique on cushing disease outcome using strict remission criteria. Can J Neurol Sci (2013) 0.76
Correction: Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population. PLoS One (2016) 0.75
Generation of an attenuated Tiantan vaccinia virus by deletion of the ribonucleotide reductase large subunit. Arch Virol (2014) 0.75
RISK-FACTORS, PATHOGENESIS, AND PHARMACEUTICAL APPROACHES FOR TREATMENT OF STEROID-INDUCED BONE INFARCTION OF FEMORAL HEAD. Acta Pol Pharm (2016) 0.75